These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 37934565)
1. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma. Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma. Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of m Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N Front Immunol; 2022; 13():955848. PubMed ID: 36203569 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer. Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086 [TBL] [Abstract][Full Text] [Related]
5. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment. Pan W; Liu X; Liu S Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data. Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150 [TBL] [Abstract][Full Text] [Related]
7. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma. Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591 [TBL] [Abstract][Full Text] [Related]
8. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma. Xu Z; Chen S; Zhang Y; Liu R; Chen M Front Immunol; 2022; 13():869759. PubMed ID: 35603206 [TBL] [Abstract][Full Text] [Related]
9. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration. Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer. Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B Front Immunol; 2022; 13():914577. PubMed ID: 35757739 [TBL] [Abstract][Full Text] [Related]
11. Development of the expression and prognostic significance of m Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884 [TBL] [Abstract][Full Text] [Related]
12. RNA N1-methyladenosine regulator-mediated methylation modification patterns and heterogeneous signatures in glioma. Mao M; Chu Q; Lou Y; Lv P; Wang LJ Front Immunol; 2022; 13():948630. PubMed ID: 35936006 [TBL] [Abstract][Full Text] [Related]
13. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma. Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z Front Genet; 2022; 13():903117. PubMed ID: 35692827 [No Abstract] [Full Text] [Related]
14. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D Front Immunol; 2022; 13():918140. PubMed ID: 35833147 [TBL] [Abstract][Full Text] [Related]
15. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma. Pan J; Huang Z; Xu Y Front Oncol; 2021; 11():657466. PubMed ID: 34195072 [TBL] [Abstract][Full Text] [Related]
16. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine. Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C Front Immunol; 2022; 13():1049435. PubMed ID: 36532062 [TBL] [Abstract][Full Text] [Related]
17. 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas. Zhang J; Wang N; Wu J; Gao X; Zhao H; Liu Z; Yan X; Dong J; Wang F; Ba Y; Ma S; Jin J; Du J; Ji H; Hu S Front Immunol; 2022; 13():844778. PubMed ID: 35309316 [TBL] [Abstract][Full Text] [Related]
18. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma. Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056 [TBL] [Abstract][Full Text] [Related]
19. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma. Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma. Tian L; Wang Y; Tian J; Song W; Li L; Che G Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]